Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Inhibitors of NHE and their use in cardiovascular disorders claimed by BMS

Dec. 4, 2000

New PARP inhibitors presented by BASF for use in neurological, neurodegenerative disorders

Dec. 4, 2000

CDK-inhibitory pyrazolobenzodiazepines for cancer

Dec. 4, 2000

Selective NK3 receptor antagonists patented by Neurogen R&D team

Dec. 1, 2000

Dual 5-HT1A ligands/5-HT transporter inhibitors under study at AHP for depression

Dec. 1, 2000

CRC describes new prodrugs for cancer ADEPT or GDEPT

Dec. 1, 2000

Novo Nordisk/Boehringer Ingelheim collaboration discovers new series of H3 receptor antagonists

Dec. 1, 2000

Bisanthraquinone antibacterial agents reported by Yamanouchi

Dec. 1, 2000

Potential new agents for asthma selectively inhibit human PDE4

Dec. 1, 2000

SMP-2: new polyene antifungal antibiotic identified by Ajinomoto

Dec. 1, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...